Cuproptosis诱导的功能纳米复合材料用于增强和协同的癌症放射治疗
Tiaoyan Jiang1, Tianying Jia1, Yipengchen Yin1
1Department of Radiation Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, P. R. China.
ACS nano
|February 3, 2025
概括
这项研究介绍了Lipo-Ele@CuO2,一种纳米脂质体,可以将铜输送到瘤细胞线粒体中. 这通过诱导cuproptosis来增强放射治疗,改善癌症治疗和安全性.
科学领域:
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
- 生物化学 生物化学
背景情况:
- 放射治疗是癌症治疗的基石,但面临着瘤耐药性的挑战.
- 瘤细胞积累铜,这有助于它们的生长和抵抗放射治疗.
- 向线粒体输送铜的向提供了一种提高放射治疗疗效的策略.
研究的目的:
- 开发一个多功能纳米脂质体复合体,Lipo-Ele@CuO2,用于针对性地将铜输送到瘤细胞线粒体.
- 为了研究Lipo-Ele@CuO2的潜力,诱导cuproptosis和增强放射治疗的疗效.
- 评估这种组合治疗的抗瘤作用和安全性.
主要方法:
- 设计了一个纳米脂质体复合体 (Lipo-Ele@CuO2),封装了过氧化铜 (CuO2) 和 elesclomol.
- 在酸性瘤微环境中研究了对pH反应的铜离子释放.
- 进行了体外和体内研究,以评估抗瘤疗效,安全性和cuproptosis诱导.
- 进行了代谢学和转录学分析,以阐明潜在的机制.
主要成果:
- Lipo-Ele@CuO2成功地将铜离子输送到线粒体,诱导瘤细胞中的亡.
- 组合疗法协同增强了放射治疗的疗效,导致显著的瘤生长抑制.
- 在体外和体外研究表明,抗瘤活性改善,安全性较好.
- 代谢和转录基因数据证实了通过改变瘤能量代谢和抑制关键基因来诱导cuproptosis.
结论:
- 基于Lipo-Ele@CuO2的疗法是克服放射治疗耐药性的有希望的策略.
- 通过Lipo-Ele@CuO2将铜向线粒体的向输送有效地诱导了cuproptosis并强化了放射治疗.
- 这种方法显示了临床癌症治疗的显著翻译潜力.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
01:27Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464